Given recent data hinting at altered neuroplasticity in MDD, as well as data tying ketamine's fast-acting antidepressant effects to glutamate-dependent changes in dendritic plasticity (Li et al., 2010, 2011), Arc may represent an important mechanism for study in preclinical models of depression. The gene discussed is ARC; the disease is major depressive disorder.